Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Moxonidine (Primary) ; Bisoprolol
- Indications Hypertension; Metabolic bone diseases
- Focus Biomarker; Pharmacodynamics
- Acronyms COMPASS
- 07 Jun 2017 Biomarkers information updated
- 29 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Sep 2017.
- 20 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.